Asia
It was a busy week for clinical trial announcements. Here’s a look.
FUJIFILM Corporation will invest 13 billion yen (about $120 million) to expand the company’s gene therapy business and establish a new Gene Therapy Innovation Center adjacent to its current facility in College Station, Texas and add about 100 jobs.
It is the first BeiGene-discovered drug to be approved.
The U.S. Food and Drug Administration approved Shionogi’s Fetroja as a treatment for adult patients with complicated urinary tract infections caused by a number of Gram-negative microorganisms.
Establishing a New Gene Therapy Drug Process Development Building and Expanding Product Facilities in Texas, USA
Circulating Tumor Cells (CTC) analysis has great potential to transform the cancer diagnostic landscape
Life sciences companies strengthen their leadership teams with this week’s appointments.
The company discontinued development earlier this year, but a shortage prompted the reversal.
The letter outlines multiple failures, including failure to have adequate written procedures for the receipt, identification and handling of raw materials and failure to adequately clean equipment and utensils.
Radiologists and care providers around the world will have access to MaxQ AI’s ACCIPIO® ICH and Stroke Platform through Arterys’ cloud-native medical imaging platform.
PRESS RELEASES